Literature DB >> 9917015

Problems with interval estimates of the incremental cost-effectiveness ratio.

D F Heitjan1, A J Moskowitz, W Whang.   

Abstract

The defining feature of a confidence interval is that it has a fixed minimum probability of covering the true value of the parameter being estimated, whatever the value of the parameter. The authors demonstrate by simulation that some recently proposed methods for interval estimation of the incremental cost-effectiveness ratio (ICER) either do not satisfy this definition or have other problems that limit their usefulness in applications. The problems are most prominent when the ICER is large and the true effectiveness difference is small relative to its standard error. A modification of the percentile bootstrap confidence interval that involves a reordering of the sample space provides a partial solution of the problem.

Mesh:

Year:  1999        PMID: 9917015     DOI: 10.1177/0272989X9901900102

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  10 in total

Review 1.  Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.

Authors:  A O'Hagan; J W Stevens; J Montmartin
Journal:  Pharmacoeconomics       Date:  2000-04       Impact factor: 4.981

2.  Cost-effectiveness analysis: a proposal of new reporting standards in statistical analysis.

Authors:  Heejung Bang; Hongwei Zhao
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

3.  Management of common bile duct stones in cirrhotic patients with coagulopathy: a comparison of supra-papillary puncture and standard cannulation technique.

Authors:  Everson L A Artifon; Eduardo B da Silveira; Dayse Aparicio; Jonas Takada; Renato Baracat; Christiano M Sakai; Ruel T Garcia; Vanessa Teich; Decio S Couto
Journal:  Dig Dis Sci       Date:  2011-02-12       Impact factor: 3.199

4.  Net benefit separation and the determination curve: A probabilistic framework for cost-effectiveness estimation.

Authors:  Andrew J Spieker; Nicholas Illenberger; Jason A Roy; Nandita Mitra
Journal:  Stat Methods Med Res       Date:  2021-04-07       Impact factor: 3.021

5.  Median-Based Incremental Cost-Effectiveness Ratio (ICER).

Authors:  Heejung Bang; Hongwei Zhao
Journal:  J Stat Theory Pract       Date:  2012-08-10

6.  Assessing technological change in cardiothoracic surgery.

Authors:  Alexander Iribarne; Mark J Russo; Alan J Moskowitz; Deborah D Ascheim; Lawrence D Brown; Annetine C Gelijns
Journal:  Semin Thorac Cardiovasc Surg       Date:  2009

7.  Cost-effectiveness of palliation of unresectable esophageal cancer.

Authors:  Eduardo B da Silveira; Everson L Artifon
Journal:  Dig Dis Sci       Date:  2008-06-04       Impact factor: 3.199

8.  Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study.

Authors:  Linda Kemp; John Haughney; Neil Barnes; Erika Sims; Julie von Ziegenweidt; Elizabeth V Hillyer; Amanda J Lee; Alison Chisholm; David Price
Journal:  Clinicoecon Outcomes Res       Date:  2010-07-01

9.  Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation.

Authors:  Elisabeth Fenwick; Deborah A Marshall; Adrian R Levy; Graham Nichol
Journal:  BMC Health Serv Res       Date:  2006-04-19       Impact factor: 2.655

10.  Joint distribution approaches to simultaneously quantifying benefit and risk.

Authors:  Michele L Shaffer; Kristi L Watterberg
Journal:  BMC Med Res Methodol       Date:  2006-10-12       Impact factor: 4.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.